Importantly, serum GRP78 levels were found to be significantly higher in COVID-19 patients compared to the control groups, and leukocyte surface expression of GRP78 was increased in severe COVID-19 cases [20,30]. This evidence concerns the gene HSPA5 and COVID-19.